Literature DB >> 3931454

Duration of whirlpool-spa use as a risk factor for Pseudomonas dermatitis.

P J Hudson, R L Vogt, D A Jillson, S J Kappel, A K Highsmith.   

Abstract

Pseudomonas dermatitis occurred among 16 of 49 whirlpool-spa bathers in a Vermont hotel during a weekend in November 1983. Pseudomonas aeruginosa, serotype 0:4, was isolated from a patient and the whirlpool-spa water. Since duration of whirlpool-spa use had been previously postulated as a risk factor for dermatitis, a historical cohort study was designed to test this hypothesis. Each bather was carefully interviewed about the duration in minutes of whirlpool-spa and swimming pool exposure on the weekend. Total duration of whirlpool-spa use was significantly associated with rash illness both on contingency and logistic regression analysis. Females were also found to be at increased risk, after controlling for the study hypothesis. Duration of whirlpool-spa use was an important determinant of risk for Pseudomonas dermatitis in this outbreak.

Entities:  

Mesh:

Year:  1985        PMID: 3931454     DOI: 10.1093/oxfordjournals.aje.a114175

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  4 in total

Review 1.  Whirlpool-associated folliculitis caused by Pseudomonas aeruginosa: report of an outbreak and review.

Authors:  S Ratnam; K Hogan; S B March; R W Butler
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

2.  Whirlpool folliculitis.

Authors:  G Birkhead; R L Vogt; P J Hudson
Journal:  Am J Public Health       Date:  1987-04       Impact factor: 9.308

3.  Dose-response algorithms for water-borne Pseudomonas aeruginosa folliculitis.

Authors:  D J Roser; B Van Den Akker; S Boase; C N Haas; N J Ashbolt; S A Rice
Journal:  Epidemiol Infect       Date:  2014-10-02       Impact factor: 4.434

Review 4.  Pseudomonas aeruginosa dose response and bathing water infection.

Authors:  D J Roser; B van den Akker; S Boase; C N Haas; N J Ashbolt; S A Rice
Journal:  Epidemiol Infect       Date:  2013-11-08       Impact factor: 4.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.